Accepts · Advanced · Application · First · Indication · Line · Nmpa · Sacituzumab · Tirumotecan · Tnbc

NMPA Accepts New Indication Application for Sacituzumab Tirumotecan ( sac - TMT ) as First - Line Treatment for Advanced TNBC

Covered by 1 of 116 currently active countries' press · not covered by: United Arab Emirates, Afghanistan, Algeria, Azerbaijan, Albania, Armenia, Angola, Argentina, Australia, Austria, Bahrain, Belgium…